Wells Fargo initiated coverage on Arcus Biosciences with a new price target
$RCUS
Biotechnology: Pharmaceutical Preparations
Health Care
Wells Fargo initiated coverage of Arcus Biosciences with a rating of Overweight and set a new price target of $29.00